0001209191-21-030121.txt : 20210504
0001209191-21-030121.hdr.sgml : 20210504
20210504195141
ACCESSION NUMBER: 0001209191-21-030121
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20201210
FILED AS OF DATE: 20210504
DATE AS OF CHANGE: 20210504
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: TANG KEVIN C
CENTRAL INDEX KEY: 0001178579
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36282
FILM NUMBER: 21890618
MAIL ADDRESS:
STREET 1: 4747 EXECUTIVE DRIVE
STREET 2: SUITE 210
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: LA JOLLA PHARMACEUTICAL CO
CENTRAL INDEX KEY: 0000920465
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 330361285
STATE OF INCORPORATION: CA
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 4747 EXECUTIVE DRIVE, SUITE 240
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
BUSINESS PHONE: 858-207-4264
MAIL ADDRESS:
STREET 1: 4747 EXECUTIVE DRIVE, SUITE 240
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2020-12-10
0
0000920465
LA JOLLA PHARMACEUTICAL CO
LJPC
0001178579
TANG KEVIN C
4747 EXECUTIVE DRIVE, SUITE 210
SAN DIEGO
CA
92121
1
0
1
0
Stock Option (Right to Buy)
4.53
2020-12-10
4
A
0
30000
0.00
A
2030-12-10
Common Stock
30000
30000
D
The late filing of the reported transaction is due to an inadvertent administrative error.
The stock options vest and become exercisable on December 10, 2021, subject to the Reporting Person's continued service to the Issuer through such date.
/s/ Kevin Tang
2021-05-04